American Century Companies’s Whitehawk Therapeutics WHWK Stock Holding History

American Century Companies’s Portfolio WHWK Stock Details WHWK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$237K	Buy	+51,840	New	+$216K	﹤0.01%	2749

Other funds holding WHWK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

American Century Companies's WHWK Position: Q2 2026 in Review

American Century Companies opened a new position in Whitehawk Therapeutics (WHWK) in Q2 2026: 51,840 shares worth $237K. The stake represents ﹤0.01% of the portfolio and ranks #2749 among its holdings.

27 funds tracked by Wall St. Rank hold WHWK as of Q2 2026.

American Century Companies held 51,840 shares of Whitehawk Therapeutics worth $237K as of Q2 2026.
Whitehawk Therapeutics was a new American Century Companies position in Q2 2026.
Whitehawk Therapeutics made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2749 holding.
27 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.